Ambucay, Dolina E.
HRN: 28-64-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/02/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
03/02/2026
03/08/2026
IV
2.25g
Q6h
Cap Mr
Pending Pharmacy Acceptance
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: